GENSPEED Biotech and axiVEND Announce a Collaboration Agreement
Summary
The GENSPEED platform is a compact, fast and simple system to enable multiplex testing at the point of care. With its novel combination of microfluidics, miniaturized opto-electronics and automation GENSPEED® enables the simultaneous detection of multiple analytes at the point of care within a few minutes. Thus, the platform facilitates the rapid identification of defined bacteria or viruses as well as the quantitation of certain biomarkers in blood or other biological material. From the Greek “axios” for truthfulness, axiVEND promises to provide the very best solutions, with proven field performance, to the worlds of diagnostics and multiplex assays. Leveraging an expanded network throughout North and South America, axiVEND will soon be positively impacting life science industries in general.